Compare CDMOs specializing in small molecule API synthesis from route scouting through commercial manufacturing. Filter by chemistry capabilities, scale, and regulatory approvals.
517 companies listed
For a small molecule API, the synthetic route is the program. A CDMO's process chemists decide how you get from raw materials to drug substance: how many steps, what yield, and which impurities you'll spend the next two years explaining to regulators. Route scouting and development are where a strong API partner earns its fee. Crystallization is the part buyers underestimate. It controls polymorphic form and particle size, and a polymorph surprise during scale-up has delayed more filings than most people admit. So probe the chemistry. Have they run your reaction types (hydrogenation, cryogenic steps, flow chemistry) at kilo-lab through metric-ton scale? Is the API high-potency, needing OEB4/5 containment? Do they have ICH Q11 filings and a defensible regulatory starting material strategy? 517 CDMOs here list small molecule API synthesis. Compare them on chemistry, scale, and regulatory experience.
Active Pharmaceutical Ingredient (API) manufacturing is the chemical synthesis of the drug substance itself. For small molecules, this involves multi-step organic chemistry from raw materials to the final API, requiring expertise in reaction chemistry, purification, crystallization, and process optimization.
Process chemistry determines project success. A strong CDMO identifies the most efficient synthetic route, optimizes reaction conditions for yield and purity, and develops a process that scales reliably from gram to metric ton quantities. Crystallization expertise is particularly critical for controlling polymorphic form and particle size distribution.
China
Chengdu Pukang Biotechnology Co., Ltd. is a Chinese company specializing in peptide building blocks, Fmoc-amino acid derivatives, and custom peptide synthesis reagents for research use. The company supplies peptide synthesis reagents rather than manufacturing finished pharmaceutical products under contract.
China
EnBridge PharmTech is a Chinese pharmaceutical company founded in 2013 in Wuxi, offering CRO and CDMO services for pharmaceutical intermediates and APIs. The company operates an R&D center and a GMP-compliant manufacturing base with large-scale reactors capable of high pressure, high temperature, and low temperature reactions, exporting to the USA, Japan, India, and Europe.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.